Invention Grant
US08389016B2 Use of a CD28 binding substance for making a pharmaceutical composition
有权
使用CD28结合物质制备药物组合物
- Patent Title: Use of a CD28 binding substance for making a pharmaceutical composition
- Patent Title (中): 使用CD28结合物质制备药物组合物
-
Application No.: US12251039Application Date: 2008-10-14
-
Publication No.: US08389016B2Publication Date: 2013-03-05
- Inventor: Thomas Hunig
- Applicant: Thomas Hunig
- Applicant Address: RU Moscow
- Assignee: Theramab LLC
- Current Assignee: Theramab LLC
- Current Assignee Address: RU Moscow
- Agency: Mayer & Williams PC
- Agent Keum J. Park, Esq.
- Priority: DE10212108 20020313
- Main IPC: A61K35/14
- IPC: A61K35/14
Abstract:
The invention relates to the use of a CD28-specific superagonistic monoclonal antibody (mAb) or of a mimicry compound hereto for making a pharmaceutical composition for the induction and/or multiplication of regulatory T cells.
Public/Granted literature
- US20090246204A1 USE OF A CD28 BINDING SUBSTANCE FOR MAKING A PHARMACEUTICAL COMPOSITION Public/Granted day:2009-10-01
Information query
IPC分类:
